arrow
S

Stéphanie Poulain

University of Lille
H指数:22
被引数:1,763

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Single-cell genomics highlight MYC-associated metabolic activation and altered cell interactions in T-prolymphocytic leukemia progression

单细胞基因组学揭示了MYC相关的代谢激活以及在T原淋巴细胞白血病进展中改变的细胞相互作用

2026-03-090
OAAI
Late toxicity and long-term efficacy of first-line bendamustine and rituximab combination in patients with Waldenström macroglobulinemia

Waldenström巨球蛋白血症患者一线苯达莫司汀联合利妥昔单抗方案的晚期毒性和长期疗效

Leukemia
IF13.4
2025-12-090
PRE
Waldenström’s macroglobulinemia: the LYSA pragmatic guidelines

华氏巨球蛋白血症:LYSA实用指南

2025-11-280
PRE
Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study

靶向治疗克服了类型#2慢性淋巴细胞白血病的较差预后:一项真实世界多中心研究

LEUKEMIA
IF13.4
2025-04-010
OA
Inflammatory Waldenstrom Macroglobulinemia Is Associated with Clonal Hematopoiesis: A Multicentric Cohort

炎症性华氏巨球蛋白血症与克隆性造血相关:一项多中心队列研究

BLOOD
IF23.1
2024-11-050
PRE
Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström's macroglobulinemia
2024-11-050
OAAI
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression

蕈样肉芽肿的基因组分析可确定疾病进展的高风险患者

2024-06-130
OAAI
The Broad Spectrum of TP53 Mutations in CLL: Evidence of Multiclonality and Novel Mutation Hotspots
2023-05-090
OAAI
Report of Consensus Panel 3 from the 11th International workshop on Waldenstrom's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenstrom's Macroglobulinemia

第11届瓦尔登斯特伦巨球蛋白血症国际研讨会共识小组3的报告: 瓦尔登斯特伦巨球蛋白血症的分子诊断建议

2023-03-019
OAAI
Diagnostics in Waldenstrom's macroglobulinemia: a consensus statement of the European Consortium for Waldenstrom's Macroglobulinemia
LEUKEMIA
IF13.4
2022-11-2622
OAAI
TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia
2022-02-013
OAAI
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO)
2021-07-011
OAAI
Rationale for the combination of venetoclax and ibrutinib in T-prolymphocytic leukemia
2021-02-257
OAAI
Guideline for the diagnosis, treatment and response criteria for Bing-Neel syndrome
2016-10-06105
OAAI